WCM
PJP icon

Weatherstone Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Weatherstone Capital Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-62,240
Closed -$2.87M – 89
2013
Q3 		$2.87M Sell
62,240
-2,939
-5% -$134K 0.75% 22
2013
Q2 		$2.77M Buy
+65,179
New +$2.71M 1.18% 23

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
SCM
Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Weatherstone Capital Management's PJP Position: Q4 2013 in Review

Weatherstone Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2013, closing a stake of 62,240 shares — an estimated $2.87M sold.

Weatherstone Capital Management first reported a position in PJP in Q2 2013 and held it in 2 quarters. The position peaked at $2.87M in Q3 2013. 71 funds tracked by Wall St. Rank hold PJP as of Q4 2013.

  • Weatherstone Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2013 after selling out during the quarter.
  • Weatherstone Capital Management sold 62,240 Invesco Pharmaceuticals ETF shares in Q4 2013, an estimated $2.87M.
  • Weatherstone Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 2 quarters.
  • Weatherstone Capital Management's Invesco Pharmaceuticals ETF position peaked at $2.87M in Q3 2013.
  • 71 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2013.

Based on Weatherstone Capital Management's 13F filing for Q4 2013, filed 18 Feb 2014.